Literature DB >> 17579204

Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis.

Irena Hainerová1, Lesli H Larsen, Birgitte Holst, Marie Finková, Vojtech Hainer, Jan Lebl, Torben Hansen, Oluf Pedersen.   

Abstract

BACKGROUND: Mutations in the melanocortin 4 receptor gene (MC4R) represent the most common known cause of monogenic human obesity. AIMS: The aims of this study were the following: 1) to estimate the prevalence of MC4R mutations in obese Czech children; 2) to evaluate phenotypic features of the mutation carriers; 3) to compare weight, height, and body mass index of MC4R mutation carriers with noncarriers in longitudinal studies; 4) to determine the effect of a weight management program among MC4R mutation carriers; and 5) to perform a functional analysis of a novel variant. SUBJECTS AND METHODS: We analyzed the coding region of MC4R in a cohort of 289 Czech children and adolescents with early-onset obesity by direct sequencing. Information on weight, height, body mass index, baseline biochemical data, and a weight loss follow-up study was obtained. In vitro functional analysis of one novel variant was performed.
RESULTS: We identified six different mutations in seven probands: one novel missense mutation Cys84Arg and five previously reported variants, Arg7Cys, Ser19fsdelA, Phe51Leu, Ser127Leu, and Gly181Asp. The Gly181Asp variant was detected in one homozygous carrier from unrelated parents. None of the mutation carriers fulfilled the MC4R syndrome criteria. A comparison of anthropometrics in mutation carriers and noncarriers during 13 yr of follow-up did not reveal any significant differences. MC4R mutation carriers exhibited a similar ability to lose weight as obese noncarriers. The novel variant Cys84Arg showed a significant reduction in cAMP signal properties of the MC4R.
CONCLUSIONS: Among obese Czech children, we found a prevalence of 2.4% of MC4R homozygous and heterozygous mutations and showed a similar response to diet management of MC4R mutation carriers and noncarriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579204     DOI: 10.1210/jc.2007-0352

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Identification and functional characterization of novel mutations in the melanocortin-4 receptor.

Authors:  Sigri Beckers; Doreen Zegers; Fenna de Freitas; Armand V Peeters; Stijn L Verhulst; Guy Massa; Luc F Van Gaal; Jean-Pierre Timmermans; Kristine N Desager; Wim Van Hul
Journal:  Obes Facts       Date:  2010-10-15       Impact factor: 3.942

2.  Melanocortin-4-receptor autoantibodies: a new player in obesity.

Authors:  Chandra Mohan; Anil K Agarwal
Journal:  J Clin Endocrinol Metab       Date:  2009-03       Impact factor: 5.958

3.  Celastrol Reduces Obesity in MC4R Deficiency and Stimulates Sympathetic Nerve Activity Affecting Metabolic and Cardiovascular Functions.

Authors:  Kenji Saito; Kevin C Davis; Donald A Morgan; Brandon A Toth; Jingwei Jiang; Uday Singh; Eric D Berglund; Justin L Grobe; Kamal Rahmouni; Huxing Cui
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

4.  Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks.

Authors:  Irena Aldhoon Hainerová; Hana Zamrazilová; Dana Sedláčková; Vojtěch Hainer
Journal:  Obes Facts       Date:  2011-07-28       Impact factor: 3.942

5.  Differential expression of the melanocortin-4 receptor in male and female C57BL/6J mice.

Authors:  HaiE Qu; JianPing Li; Wei Chen; YuMei Li; Qian Jiang; HuaiZhi Jiang; JinLong Huo; ZhiHui Zhao; Bo Liu; QiaoLing Zhang
Journal:  Mol Biol Rep       Date:  2014-02-01       Impact factor: 2.316

6.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

Review 7.  Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).

Authors:  V Hainer; I Aldhoon Hainerová; M Kunešová; R Taxová Braunerová; H Zamrazilová; B Bendlová
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

8.  Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

9.  Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity.

Authors:  Jing Cui; Yi Ding; Shu Chen; Xiaoqiang Zhu; Yichen Wu; Mingliang Zhang; Yaxin Zhao; Tong-Ruei R Li; Ling V Sun; Shimin Zhao; Yuan Zhuang; Weiping Jia; Lei Xue; Min Han; Tian Xu; Xiaohui Wu
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

Review 10.  Lessons from extreme human obesity: monogenic disorders.

Authors:  Sayali A Ranadive; Christian Vaisse
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.